Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T22:34:47.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:40:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays software revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T22:26:26.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The history now shows a new revision, v3.7.0, replacing the previous v3.6.6. This indicates an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-19T22:17:28.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The record history shows an updated revision tag: v3.6.6 replaces the previous v3.6.5, indicating a metadata update to the study record. No substantive study data or content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T19:00:00.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry is added: v3.6.5, signaling a newer version of the study record and replacing the previous v3.6.4 entry.
    Difference
    0.1%
    Check dated 2026-08-08T17:50:21.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.